Onconetix
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Profit margin reached -63986%. Total operating expenses were $33,721,800.

Profit Margin

Onconetix, Inc. (NASDAQ:ONCO): Profit margin
2019 0 -821.91K
2020 0 -1.59M
2021 0 -3.41M
2022 0 -13.41M
2023 58.46K -37.40M -63986.48%

ONCO Income Statement (2019 – 2023)

2023 2022 2021 2020 2019
Revenue
Revenue
58.46K0000
Cost of revenue
1.18M6.75K4.89K3.05K573
Gross profit
-1.12M-6.75K-4.89K-3.05K-573
Operating exp.
Research and development
1.94M4.12M1.32M524.90K60.17K
Selling and marketing
00000
Total operating expenses
33.72M13.48M3.41M1.62M879.65K
Operating income
-36.03M-13.48M-3.41M-1.62M-880.23K
Other income (expenses), net
-1.38M61.41K-422.60K58.31K
Income before tax
-37.42M-13.41M-3.41M-1.59M-821.91K
Income tax expense
-12.59K-61.41K-4-203.24K-3
Net income
-37.40M-13.41M-3.41M-1.59M-821.91K
Earnings per share
Basic EPS
-2.19-1.09-0.31-0.14-0.07
Diluted EPS
-2.19-1.09-0.31-0.14-0.07
Data source